Search
English
RSS

New Items

Picture of Abbott Panbio COVID-19 Antigen Self-Test (10 Individual Tests)

Abbott Panbio COVID-19 Antigen Self-Test (10 Individual Tests)

The Panbio™ COVID-19 Antigen Self-Test is a single-use, in vitro (i.e. outside the body) visually read rapid immunoassay that uses a nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen (Ag). The Panbio™ COVID-19 Antigen Self-Test is intended to be used manually by users for self-testing in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. Children under 14 years should be supported by an adult.

  • HK$880/ 10 Packs
  • Free Shipping
  • Expiry Date: January 2024
  • HK$880.00
    Picture of Post COVID-19 Recovery Health Assessment (Advanced Plan)

    Post COVID-19 Recovery Health Assessment (Advanced Plan)

    The COVID-19 epidemic is still rampant across the globe, as of 30 March 2022, over 480 million cases have been reported worldwide, and 1.14 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Advanced Plan) has been launched which included all health check-up items of “Essential Plan”, also covered COVID-19 antibody test, resting ECG, ultrasound screening and ferritin test, offering comprehensive and holistic care for the recovered persons.
    HK$4,380.00 HK$2,899.00
    Picture of Post COVID-19 Recovery Health Assessment (Essential Plan)

    Post COVID-19 Recovery Health Assessment (Essential Plan)

    The COVID-19 epidemic is still rampant across the globe, as of 30 March 2022, over 480 million cases have been reported worldwide, and 1.14 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Essential Plan) has been launched which incorporates the examination of inflammation, chest X-Ray, liver and renal function for understanding the health status better.
    HK$1,580.00 HK$899.00
    Picture of Abbott Panbio COVID-19 Antigen Self-Test (Individual Kit)

    Abbott Panbio COVID-19 Antigen Self-Test (Individual Kit)

    The Panbio™ COVID-19 Antigen Self-Test is a single-use, in vitro (i.e. outside the body) visually read rapid immunoassay that uses a nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen (Ag). The Panbio™ COVID-19 Antigen Self-Test is intended to be used manually by users for self-testing in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. Children under 14 years should be supported by an adult.

  • HK$99/Pack
  • Free Shipping on order 6 packs or above
  • Expiry Date: January 2024
  • HK$99.00
    Picture of AESKU COVID -19 Rapid Antigen Test (2 Tests)

    AESKU COVID -19 Rapid Antigen Test (2 Tests)

    AESKU COVID-19 Rapid Antigen Test is an immunological method that is using nasal swab specimen for the qualitative detection of SARS-CoV-2 antigens. It is able to detect the presence of certain COVID-19 variants (Omicron and Delta)^. AESKU COVID-19 Rapid Antigen Test is developed and made in Germany, being externally evaluated by ESfEQA and CE-certified, and is being used by multiple private hospitals in Hong Kong for detecting the presence of COVID-19. The rapid antigen test is easy and convenient, allowing users to perform the tests on their own, and results to be illustrated in 15 minutes. There are 2 sets of test device inside 1 pack, which allows double confirmation upon suspected positive cases. The test is eligible for people of all ages, and any person under 12 years should be accompanied by adults.

    Our first batch of “AESKU Covid-19 Rapid Antigen Test” sales received an overwhelming response and were sold out. To safeguard your health and thanks for your ongoing support, the second batch will be up for grabs again at below discount price:
  • HK$188/Pack
  • Free Shipping on order 3 packs or above

    Expiry Date: April 2023
  • HK$188.00
    Picture of COVID-19 Pre-vaccination Health Assessment

    COVID-19 Pre-vaccination Health Assessment

    The vaccine pass scheme have been covered to all restaurants, schools and gym centres and etc. All citizens is required to present vaccination record for accessing scheduled premises. In other words, the Government is encouraging the citizens to make appointments for vaccinations as soon as possible. “COVID-19 Pre-vaccination Health Assessment” can be served as a vaccination risk assessment to discover any potential health issues, meanwhile can be taken as a general health assessment for understanding the health status better. Whether taking Sinovac or BioNTech vaccine, pre-vaccination health assessment can help relieve the stress and anxiety towards vaccination.
    HK$2,599.00 HK$1,188.00
    INDICAID

    INDICAID® COVID-19 Rapid Antigen Test (25 Test Kits)

    INDICAID® offers user-friendly rapid antigen test, which can be used anytime, anywhere without the need of special equipment or facility. It is designed for qualitative detection of antigens in direct nasal swab samples, where the intuitive visual result will be shown in 20 minutes. The product is developed in Hong Kong, and is authorized by EU CE and Hong Kong Government for use. Moreover, it is recognized by Residential Care Homes for the Elderly (RCHE), Residential Care Homes for Persons with Disabilities (RCHD) and marathon. The rapid antigen test is clinically validated with overall sensitivity and specificity at 96% and 99% respectively.
    HK$3,000.00
    Picture of Quadrivalent Influenza Vaccine (Flublok®)

    Quadrivalent Influenza Vaccine (Flublok®)

    Produced as quadrivalent recombinant influenza vaccine, Flublok® is considered to be the next generation of influenza immunization, and is classified as the competent seasonal influenza vaccination for the 2021/2022 season in Hong Kong. Any individual aged 18 years or above will be eligible for taking the quadrivalent vaccine, and it could yield better protection than the traditional influenza vaccines. Comparing to the standard quadrivalent inactivated influenza vaccine, it is proven to be 30% more effective in preventing flu for the population aged 50 years or above, and the hemagglutinin (HA) antigen per strain is triple to the ordinary vaccine as well. Apart from that, the new vaccine can offer 40% additional cross-protection than standard vaccine, i.e. can still offer protection to the recipients towards virus strains other than those specified in vaccine.
    HK$495.00
    Picture of COVID-19 Pre-booster Vaccination Health Assessment

    COVID-19 Pre-booster Vaccination Health Assessment

    In order to reinforce the protection against COVID-19, COVID-19 vaccine booster regime is introduced in Hong Kong, to further enhance the efficacy of the vaccines. Meanwhile, health condition is the major concern for certain people, whether taking the COVID-19 booster shot is an eligible option. COVID-19 Pre-booster Vaccination Health Assessment has been launched, which incorporates the examination of cardiovascular disease risk factors, aiming to relieve any anxiety or doubt towards myocarditis, particularly for the elderly and high-risk groups. The assessment also includes two COVID-19 antibody tests, for tracking the antibody level after the booster dose, which also allows people to have a much more comprehensive preparation for the third dose.
    HK$1,780.00
    Picture of Quadrivalent Influenza Vaccine

    Quadrivalent Influenza Vaccine

    Seasonal influenza is a common respiratory tract infection caused by human seasonal influenza viruses. The influenza viruses could be transmitted through respiratory droplets, and could be latent for 1-4 days. At the onset of influenza, the infected individual will manifest symptoms including malaise, runny nose, headache, coughing, fever and sore throat and etc. In Hong Kong, seasonal influenza is usually prevalent in months like from January to March and from July to August. Quadrivalent influenza vaccine is eligible for individuals aged 6 months or above, and is advised to be taken for comprehensive protection against influenza.
    HK$300.00